Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients
Clinical trial NCT00129376 · COMPLETED
Trial details
- NCT number
- NCT00129376
- Sponsor
- Spanish Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2005-07-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.